Codexis, Inc. (0I0X.L)

USD 5.58

(-2.26%)

Total Debt Summary of Codexis, Inc.

  • Codexis, Inc.'s latest annual total debt in 2023 was 22.36 Million USD , down -48.75% from previous year.
  • Codexis, Inc.'s latest quarterly total debt in 2024 Q2 was 42.53 Million USD , down -1.57% from previous quarter.
  • Codexis, Inc. reported annual total debt of 43.63 Million USD in 2022, down -8.43% from previous year.
  • Codexis, Inc. reported annual total debt of 47.65 Million USD in 2021, up 90.99% from previous year.
  • Codexis, Inc. reported quarterly total debt of 43.21 Million USD for 2024 Q1, up 93.23% from previous quarter.
  • Codexis, Inc. reported quarterly total debt of 42.53 Million USD for 2024 Q2, down -1.57% from previous quarter.

Annual Total Debt Chart of Codexis, Inc. (2023 - 2006)

Historical Annual Total Debt of Codexis, Inc. (2023 - 2006)

Year Total Debt Total Debt Growth
2023 22.36 Million USD -48.75%
2022 43.63 Million USD -8.43%
2021 47.65 Million USD 90.99%
2020 24.95 Million USD -4.47%
2019 26.11 Million USD 42716.39%
2018 61 Thousand USD -79.8%
2017 302 Thousand USD -28.94%
2016 425 Thousand USD 0.0%
2015 425 Thousand USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD -100.0%
2009 7.94 Million USD -40.5%
2008 13.34 Million USD -23.32%
2007 17.4 Million USD 327.38%
2006 4.07 Million USD 0.0%

Peer Total Debt Comparison of Codexis, Inc.

Name Total Debt Total Debt Difference
Xeris Biopharma Holdings, Inc. 229.19 Million USD 90.242%
Arrowhead Pharmaceuticals, Inc. 115.17 Million USD 80.582%
Viridian Therapeutics, Inc. 21.04 Million USD -6.252%
Organovo Holdings, Inc. 1.39 Million USD -1504.304%